Robeco Euro Cash Assigned 'AAAm' Principal Stability Fund Rating Sep 08

  • ID: 1713471
  • September 2008
  • Standard & Poors
1 of 3

LONDON (Standard & Poor's) Sept. 1, 2008--Standard & Poor's Ratings Services said today that it assigned its highest principal stability fund rating of 'AAAm' to Robeco Euro Cash, a French-domiciled Fonds Commun de Placement (FCP). The rating is based on Standard & Poor's analysis of the fund's credit quality, liquidity, market price exposure, and management. Banque Robeco, fund sponsor of the Robeco Euro Cash, has established the fund to offer institutional and corporate investors a high level of current income and daily liquidity, as is consistent with the preservation of capital. The assigned rating reflects the fund's extremely strong capacity to maintain principal stability and to limit exposure to principal losses due to credit, market, and/or liquidity risks. The fund...

Companies mentioned in this report are:
- Cooperatieve Rabobank U.A.
- BNP Paribas

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Cooperatieve Rabobank U.A.
- BNP Paribas

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.